Connection
Jawahar Mehta to Cyclooxygenase 2 Inhibitors
This is a "connection" page, showing publications Jawahar Mehta has written about Cyclooxygenase 2 Inhibitors.
|
|
Connection Strength |
|
 |
|
 |
|
0.525 |
|
|
|
-
Marwali MR, Mehta JL. COX-2 inhibitors and cardiovascular risk. Inferences based on biology and clinical studies. Thromb Haemost. 2006 Oct; 96(4):401-6.
Score: 0.275
-
Schr?r K, Mehta P, Mehta JL. Cardiovascular risk of selective cyclooxygenase-2 inhibitors. J Cardiovasc Pharmacol Ther. 2005 Jun; 10(2):95-101.
Score: 0.250